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Objective: The current study examined whether cognitive reactivity, cognitive extremity reactivity, and mood
reactivity following mood provocation predicted relapse in depression over 5.5 years. Additionally, this study
was the 1st to examine whether changes in cognitive reactivity and mood reactivity following preventive
cognitive therapy (PCT) mediated the preventive effect of PCT on relapse. Method: One hundred eighty-
seven remitted recurrently depressed outpatients were randomized over treatment as usual (TAU) versus TAU
 PCT with 5.5-year follow-up. Relapse in depression was assessed with the Structured Clinical Interview for
DSM–IV Axis I Disorders (Spitzer, Williams, Gibbon, & First, 1990). Results: Mood reactivity predicted time
to relapse over 5.5 years. We found no evidence that cognitive reactivity was a risk factor for relapse in
depression. Moreover, unprimed dysfunctional beliefs predicted relapse directly. There was no indication of
mediation by changes in cognitive reactivity (including extremity of the beliefs and unprimed beliefs) or mood
reactivity on the preventive effect of PCT. Further, explorative analyses revealed that increases in cognitive
and mood reactivity over time also predicted time to relapse. Conclusions: Our findings highlight a need to
focus on mood reactivity instead of beliefs as a risk factor for relapse in depression. Similar to a previous
study, we found no indications that cognitive therapy after remission reduced dysfunctional beliefs, cognitive
reactivity, or extremity. Future studies should examine cognitive reactivity and mood reactivity in daily life
as predictors of relapse.
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Major depressive disorder (MDD) is a mood disorder with
immense consequences for patients and society, and is associated
with substantially reduced quality of life stretching out far beyond
remission (Judd et al., 2000; Plaisier et al., 2010; ten Doesschate,
Koeter, Bockting, & Schene, 2010). The World Health Organiza-
tion (WHO) estimated that by 2030, MDD will rank second in
most disabling conditions worldwide (Mathers & Loncar, 2006).
Part of MDDs disabling effect is due to its high risk of relapse
that can rise to 80% in the absence of adequate treatment (Mueller
& Leon, 1999). Several risk factors for relapse have been identi-
fied, for example, early onset, number of previous episodes, re-
sidual symptoms, and episode severity (Burcusa & Iacono, 2007;
Judd et al., 1998; Kennedy & Paykel, 2004; Paykel, Ramana,
Cooper, & Hayhurst, 1995). Potentially modifiable risk factors
have been reported as well—including the impact of daily hassles
and life events, specific coping styles, decentering, and dysfunc-
tional beliefs (Beshai, Dobson, Bockting, & Quigley, 2011; Bock-
ting, Spinhoven, Koeter, Wouters, & Schene, 2006; Burcusa &
Iacono, 2007; Fresco, Segal, Buis, & Kennedy, 2007; Jarrett et al.,
2012; ten Doesschate, Bockting, & Schene, 2009).
Acute-phase cognitive therapy (A-CT) as well as preventive
cognitive therapy (PCT) focus on presumed cognitive vulnerability
factors of relapse, that is, underlying dysfunctional beliefs that are
presumed to be latent in the remitted phase, but are easily activated
by sad mood and thereby a trigger for depressive relapse. Cogni-
tive therapy (CT) after remission, including mindfulness based
cognitive therapy (MBCT), has shown to be an effective strategy
in preventing relapse in depression (Guidi, Fava, Fava, & Papa-
kostas, 2011; Piet & Hougaard, 2011; Vittengl, Clark, Dunn, &
Jarrett, 2007). Relative risk reduction (RR) of relapse when CT
after remission and MBCT were compared to non-active controls
has been documented (RR reduction CT: 36% in 232 patients; RR
reduction MBCT: 34% in 408 patients) and was especially prom-
inent in patients with three or more previous major depressive
episodes (MDEs; Piet & Hougaard, 2011; Vittengl et al., 2007).
Enduring effects of CT that start after remission have been re-
ported up to almost 6 years (Bockting, Spinhoven, Wouters,
Koeter, & Schene, 2009; Fava et al., 2004).
Since dysfunctional beliefs appeared to be dependent on mood,
both the differential activation hypothesis of Teasdale (1988) and
the mood state hypothesis of Miranda and Persons (1988) shifted
the focus from unprimed dysfunctional beliefs toward mood-
linked activation of these beliefs (i.e., cognitive reactivity [CR]) as
a risk factor for relapse in depression. Several studies have found
support for the prediction of relapse by cognitive reactivity after
remission from MDD (233 patients; Kuyken et al., 2010; Segal,
Gemar, & Williams, 1999; Segal et al., 2006). Though, one recent
study found no evidence for cognitive reactivity in patients remit-
ted from MDD (Jarrett et al., 2012), whereas Lethbridge and Allen
(2008) were unable to corroborate the predictive validity of cog-
nitive reactivity (52 patients). Unfortunately methodological con-
straints limit the interpretation of these results. Only one of Segal’s
studies (Segal et al., 2006) randomized patients over treatment
conditions. Moreover, interpretation of true mediation by change
in cognitive reactivity is limited; both Segal et al. (1999) and Segal
et al. (2006) were unable to examine pretreatment cognitive reac-
tivity as they used currently depressed patient samples, and
Kuyken et al. (2010) only measured post-treatment cognitive re-
activity as well in their sample of remitted patients.
Besides reactivity of thought content, a dichotomous “black and
white” thinking style (i.e., cognitive extremity [CE]) has also been
related to relapse in depression (Beevers, Keitner, Ryan, & Miller,
2003; Petersen et al., 2007; Teasdale et al., 2001). Cognitive
extremity predicted relapse during continuation phase and was
found to increase the risk of relapse by a factor of 2.5 (Teasdale
et al., 2001). However, other studies failed to find cognitive
extremity to predict relapse (Beevers et al., 2003; Jacobs et al.,
2010). Although we are unaware of any studies that investigated
mood-linked change in cognitive extremity (i.e., cognitive extrem-
ity reactivity [CER]), mood-linked changes in explanatory flexi-
bility (i.e., the flexibility or rigidity of assigning causes to certain
events) have been examined (Fresco, Heimberg, Abramowitz, &
Bertram, 2006; Fresco, Rytwinski, & Craighead, 2007). Following
mood-provocation, explanatory flexibility decreased in partici-
pants with a history of MDD (Fresco et al., 2006).
In addition, changes in mood itself following mood provocation
(i.e., mood reactivity [MR]) also appear to be related to relapse in
depression (Ehring, Fischer, Schnülle, Bösterling, & Tuschen-
Caffier, 2008; Ehring, Tuschen-Caffier, Schnülle, Fischer, &
Gross, 2010; Lethbridge & Allen, 2008). This implies that the
inability to effectively regulate affect during emotional or stressful
events could signal the return of depressive symptomatology.
Remitted patients who failed to show an adequate reduction in
self-rated happiness after a sad mood provocation were at in-
creased risk of relapse over 12 months (Lethbridge & Allen, 2008).
This so called emotion context insensitivity (ECI) has been asso-
ciated with poor psychosocial functioning and depression status
later in time (Peeters, Berkhof, Rottenberg, & Nicolson, 2010;
Rottenberg, Kasch, Gross, & Gotlib, 2002). Mood reactivity ap-
pears to reflect underlying stress susceptibility (Britton, Shahar,
Szepsenwol, & Jacobs, 2012), in that mood reactivity to stressful
events appears to be related to the onset of depressive symptoms
(Cohen, Gunthert, Butler, O’Neill, & Tolpin, 2005).
Few studies have focused on the underlying mechanism of
preventive CT after remission from MDD, and those that did
focused on MBCT. Two studies had inconsistent results in exam-
ining rumination as a mediator of the effect of MBCT on depres-
sive symptoms (Bieling et al., 2012; Shahar, Britton, Sbarra,
Figueredo, & Bootzin, 2010). To date, only one study directly
tested mediation by cognitive reactivity on the preventive effect of
CT on relapse (Kuyken et al., 2010), which was unable to dem-
onstrate that MBCT exerted its effects on relapse through post-
treatment cognitive reactivity. One limitation of this study is the
absence of baseline cognitive reactivity, limiting the interpretation
of possible mediating effects. Finally, a recent study demonstrated
partial mediation on the effect of MBCT on depressive symptoms
by emotional reactivity following the Trier Social Stress Task
(Britton et al., 2012). The current study is the first to examine
whether changes in cognitive reactivity and mood reactivity me-
diate the preventive effect of PCT on relapse.
The present study is a secondary analysis of a randomized trial
that investigated the effectiveness of PCT in preventing relapse in
MDD up to 5.5 years after remission (Bockting et al., 2005, 2009).
This study aims to examine whether (a) unprimed (latent) baseline
cognitive vulnerability is predictive for relapse over 5.5 years;
(b) cognitive reactivity, cognitive extremity reactivity, and mood
reactivity are predictive for relapse over 5.5 years; (c) this reac-
tivity is modifiable by brief PCT; and (d) changes in reactivity
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following treatment mediate the effect of PCT on reducing risk of
relapse.
Method
Participants
In order to participate in the current study, patients had to have
(a) experienced two or more MDEs in the previous 5 years; (b)
current remission of the last MDE for at least 10 weeks but no
longer than 2 years, both defined according to the Diagnostic and
Statistical Manual of Mental Disorders (4th ed.; DSM–IV; Amer-
ican Psychological Association, 1994) and assessed with the Struc-
tured Clinical Interview for DSM–IV Axis I Disorders (SCID-I;
Spitzer, Williams, Gibbon, & First, 1990) administered by trained
interviewers; and (c) a current score of 10 on the Hamilton
Depression Rating Scale (HDRS17; Hamilton, 1960). Exclusion
criteria were as follows: current mania, hypomania, a history of
bipolar illness, any psychotic disorder (current and previous),
organic brain damage, current alcohol or drug abuse, predominant
anxiety disorder, recent electroconvulsive therapy (ECT), recent
cognitive treatment or CT at the start of the study, or current
psychotherapy with a frequency of more than twice a month. The
protocol was approved by the institutional ethics review commit-
tees. See Bockting et al. (2005, 2009) for more details.
Design
Participants were screened for eligibility using the telephone
version of the SCID-I. Current and past depressive episodes were
checked at baseline and at five follow-up assessments (3, 12, 24,
36, and 66 months). Participants who met the inclusion criteria
were randomly allocated to (a) treatment as usual (TAU) or (b)
TAU  PCT. Randomization was performed using randomly
permuted blocks in strata of study location and type of aftercare
(general practitioner/psychiatric center/no aftercare).
Treatment
Preventive cognitive therapy. Participants in the experimen-
tal condition received eight weekly 2-hr sessions of PCT in groups
of 7–12 patients. PCT is based on Beck, Rush, Shaw, and Emery’s
(1979) acute-phase CT (Bockting et al., 2005) and focused mainly
on identification of negative thoughts and dysfunctional attitudes,
and subsequent challenging of these attitudes using different cog-
nitive techniques including Socratic dialogue (Bockting, 2009).
Moreover, participants were encouraged to practice with alterna-
tive attitudes. They were also asked to keep a diary of positive
experiences in order to enhance specific memories of positive
experiences. In the final three sessions, relapse prevention strate-
gies were formulated individually. Nine specifically trained psy-
chologists, all fully trained as cognitive behavior therapists (min-
imum 5 years of training), delivered the intervention. All
intervention group sessions were audiotaped to enable treatment
integrity evaluation, using a checklist of all particular interven-
tions. Treatment adherence was monitored between sessions, and
any adherence or competence issues were resolved with the ther-
apist prior to the subsequent session. This occurred only once,
following an overlooked homework assignment.
Treatment as usual (TAU). TAU involved “naturalistic”
care, that is, standard treatment (including primary care, specialty
care and no treatment). There was no restriction on the use of
antidepressant medication (ADM) during the period from entry
through follow-up; however, actual ADM use was monitored.
Measures
Visual Analogue Scale (VAS). Patients rated their current
mood on a Visual Analogue Scale (VAS) measuring 100 mm. The
left end of the scale was labeled “happy,” and the right end was
labeled “sad.”
Dysfunctional Attitude Scale (DAS). The 40-item Dutch ad-
aptation of the DAS (Douma, 1991; Weissman, 1979) was used to
examine levels of dysfunctional beliefs (e.g., rigid schemes or
attitudes). Patients rated their agreement with the 40-items on a
7-point scale that ranged from totally agree to totally disagree.
Two versions of the DAS (A and B) were used in the current study,
and have previously been shown to have good reliability (  .86
and .87, respectively; Dozois, Covin, & Brinker, 2003). In the
current study, both demonstrated excellent internal consistency
(  .94) and were highly correlated (r  .85).
Mood provocation procedure. Patients completed a mood
provocation procedure as described by Segal et al. (1999, 2006)
following inclusion in the study. Patients listened to a piece of
music by Prokofiev called “Russia under the Mongolian Yoke”
from the movie Alexander Nevsky. The orchestral introduction of
this musical piece was played at half speed on a tape recorder and
patients were instructed to recall a time in their life when they felt
sad. Patients first completed a VAS rating of sad mood and the
DAS-A after which Prokofiev’s piece was played for 10 min.
Immediately thereafter, patients again completed a VAS rating and
the DAS-B. An average mood change of at least 10% on the VAS
is considered to indicate successful mood provocation (Martin,
1990; Segal et al., 2006). This procedure was repeated for all
patients 3 months later.
Relapse/recurrence. Relapse has been defined as the re-
emergence of the index episode of depression within 6 months
after initial remission, whereas a recurrence is proposed to repre-
sent a new episode occurring after 12 months of recovery (Hollon,
Stewart, & Strunk, 2006). Since we included patients in remission
for at least 10 weeks but no longer than 2 years, we chose to adopt
a conservative approach. Therefore, and for sake of readability,
relapse refers to the return of a depressive episode. The main
outcome measure, time to relapse, was assessed with the SCID-I.
At the five follow-up assessments, current and MDEs preceding
the follow-up point were checked for all patients. To keep the
assessors blind to treatment condition, we instructed participants
not to reveal this information to the interviewers. Kappa () for
interrater agreement on relapse between the interviewers and an
independent psychiatrist, assessed over the follow-up period,
ranged from .94 to .96, indicating excellent agreement.
Construct operationalization. Endorsement of dysfunctional
beliefs (unprimed) was calculated by the sum score of all items on
the baseline DAS. Extremity of these beliefs was the total number
of totally agree and totally disagree responses on the DAS. Fol-
lowing mood provocation, cognitive reactivity was the change in
DAS scores, cognitive extremity reactivity was the change in
extreme responses, and mood reactivity was the change in score on
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510 VAN RIJSBERGEN ET AL.
the VAS. On an exploratory basis, we examined the course of
reactivity over time by subtracting pretreatment from post-
treatment reactivity scores.
Statistical analyses. To examine the prediction of relapse by
baseline unprimed dysfunctional beliefs (DAS-A) and cognitive
extremity on the DAS-A (CE), we used survival analysis (i.e., Cox
regression) with time to first relapse as main outcome. All analyses
were done on an intention to treat (ITT; including all randomized
patients) and completers (patients attending 5 PCT sessions)
basis. Patients who dropped-out during follow-up or who did not
relapse within 5.5 years were treated as censored in ITT and
completers analyses, meaning that their information was usefully
taken into account by the Cox model.
These analyses were then repeated separately with cognitive-,
cognitive extremity- and mood-reactivity as predictors of relapse.
We analyzed baseline, post-treatment and, on an exploratory basis, the
course of reactivity measurements following PCT (posttreatment–
pretreatment) in order to assess the mediating effect of PCT. In line
with Segal et al. (2006), we used the saved standardized residuals
(ZresDAS, ZresVAS, ZresExtremeResponses) from the linear re-
gression of pre-induction on post-induction scores as the indepen-
dent variable in the survival analysis to reduce the impact of
baseline variability.
To assess whether PCT moderated the relation between the
predictors and relapse, we examined Condition  Predictor inter-
actions and Condition  Predictor  Previous MDEs interactions
for all predictors, since in a previous study the number of previous
MDEs was a moderator in the prediction of relapse (Bockting et
al., 2005, 2009). If PCT was a significant moderator, then the
survival analysis would have to be restricted to the control group
only, otherwise the analysis could be performed on the complete
sample. All models were checked for confounding effects of
residual depressive symptoms (HDRS17) and use of ADM.
Finally, we were interested in the mediating effect of changes in
cognitive-, cognitive extremity-, and mood-reactivity on the effect
of PCT on relapse in 5.5 years. Since the effectiveness of PCT
depended on the number of previous MDEs with the cutoff point
at four previous episodes (Bockting et al., 2005, 2009), its impact
was examined in a subset of patients with four or more previous
MDEs which included more than half the sample. The effect of
PCT on the course of cognitive-, cognitive extremity-, and mood-
reactivity was determined in three separate linear regression mod-
els in which we predicted Zrespost with treatment condition and
Zrespre as independent variables. The amount of mediation of the
effect of PCT on relapse by the course of cognitive-, cognitive
extremity-, and mood-reactivity was defined as the change in
the magnitude of the effect of PCT on relapse when including the
pretreatment to post-treatment change in the Cox model as inde-
pendent variables. The amount of mediation was scaled as the
relative change in the beta coefficient (log hazard ratio) for PCT,
and was expressed as a percentage. In randomized trials this is
often called the proportion of treatment effect explained (Freed-
man, Graubard, & Schatzkin, 1992). More than a 5% change in a
regression coefficient when a covariate is added is generally con-
sidered substantial (Maldonado & Greenland, 1993).
As a previous study only used post-treatment cognitive reactiv-
ity as a mediator (Kuyken et al., 2010), we replicated these
analyses with a Cox model including PCT, post-treatment cogni-
tive reactivity, and PCT  Post-Treatment Cognitive Reactivity
interactions only, with number of previous MDEs, gender, post-
treatment HDRS17, and mood reactivity as covariates (Kuyken
et al., 2010). A significant interaction (PCT CR) and main effect
of cognitive reactivity would have indicated a mediating effect of
cognitive reactivity (Kraemer, Wilson, Fairburn, & Agras, 2002).
Results
Patient Flow
In total, 187 formerly depressed patients were randomized. For
the ITT analyses we excluded 15 patients (dropouts) in total—nine
from TAU  PCT because they did not attend any session and six
from TAU because they dropped out from the study immediately.
The resulting 172 patients were analyzed on an ITT basis. Drop-
outs were slightly younger than the ITT group, t(170)  –2.25,
p  .03, but did not differ on any of the other characteristics. For
the Completers group (n  165), we excluded an additional seven
patients who attended less than five PCT sessions. Non-
Completers were younger, t(170)  –2.85, p  .005, and had a
lower score on the DAS, t(170)  –2.01, p  .048, than Com-
pleters. A previous study on this sample demonstrated that PCT,
when added to TAU, was effective in reducing cumulative relapse
risk over 5.5 years, Wald 2(1, N  172)  8.80, p  .003, hazard
ratio 0.56. With the indicating cutoff being four previous MDEs,
dichotomized number of previous MDEs (fewer than four vs. four
or more) resulted in a significant interaction between treatment
condition and number of previous MDEs, Wald 2(1, N  172) 
7.76, p  .02, hazard ratio  0.379. The median survival time in
patients with four or more previous MDEs was 713 weeks
(TAU  PCT) compared to 205 weeks (TAU). PCT reduced
cumulative relapse over 5.5 years from 95% (TAU) to 75% (TAU
 PCT). The results were closely similar within the Completers
group (Bockting et al., 2009).
Patient Characteristics
Demographic and clinical characteristics of the ITT group are
summarized in Table 1. Patient groups did not differ on any of the
demographic variables. Initial baseline DAS-A scores differed
between conditions, F(1, 170)  4.023, p  .046. The same
differences were observed for post-treatment DAS-A and DAS-B
scores: DAS-A, F(1, 170) 3.993, p .047; DAS-B, F(1, 170)
4.477, p  .036. However, we controlled for initial DAS differ-
ences by using standardized residual DAS scores in our analyses.
No baseline differences in CR, CER, or MR were revealed and
neither did the level of CR, MR, or CER differ between patients
who were on ADM versus patients who were not.
Mood Provocation
Mood provocation at both baseline and post-treatment was
successful (average change was 10%; Martin, 1990), and in-
creased sad mood according to the VAS with, respectively, 22.9
mm and 20.8 mm in the TAU and 21.3 mm and 17.2 mm in the
TAU  PCT group (difference ns between groups).
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Interaction With Condition and Number of
Previous MDEs
For each predictor, separate Cox models were fitted including
the three-way interaction (Predictor  Condition  Previous
MDEs) and, second, including the two-way interaction
(Predictor  Condition). Since none of the interaction terms were
significant and neither depressive residual symptoms, use of
ADM, nor condition confounded the predictor of interest, interac-
tion terms were subsequently dropped from the model, and Cox
regression was fitted on the ITT sample (N  172) for each
predictor. Results on completers were not different from ITT and
were therefore omitted from the results (in the online supplemental
materials, see Tables I and II for interaction coefficients, and see
Table III for completers).
Baseline Risk of Relapse: Unprimed Dysfunctional
Beliefs and Cognitive Extremity
Cox regression revealed that dysfunctional beliefs but not cog-
nitive extremity were predictive of time to relapse in 5.5 years:
DAS-A, Wald 2(1, N  172)  12.294, p  .001, hazard ratio 
1.01; CE, Wald 2(1, N  172)  1.663, p  .197, hazard ratio 
0.99 (see Table 2). Increases in DAS-A by one unit increased
prospective risk of relapse by 1%, and DAS-A remained a signif-
icant predictor when the number of previous MDEs and depressive
symptoms were added to the model. Moreover, with cognitive
reactivity already in the model, the DAS-A also remained a sig-
nificant predictor of time to relapse.
Prediction of 5.5-Year Relapse by Cognitive Reactivity
and Cognitive Extremity Reactivity
Including all 172 patients in the Cox regression, neither baseline
cognitive reactivity nor cognitive extremity reactivity predicted
time to relapse within 5.5 years: CR, Wald 2(1, N  172) 
1.143, p  .285, hazard ratio  0.90; CER, Wald 2(1, N 
172)  0.751, p  .386, hazard ratio  1.08. Moreover, baseline
residuals for the DAS change score did not differ significantly
between patients who relapsed within 5.5 years and patients who
did not, F(1, 170)  2.292, p  .132.
Table 2
Predictors of Time to Relapse Within 5.5 Years (ITT, N  172)
Variable Predictor (	1)
Pretreatment
DASForm A
	 0.008
SE (	) 0.002
p 0.000
CE
	 
0.015
SE (	) 0.012
p 0.197
CRDAS
	 
0.101
SE (	) 0.094
p 0.285
CERDAS
	 0.073
SE (	) 0.084
p 0.386
MRVAS
	 0.021
SE (	) 0.084
p 0.807
Post-treatment
CRDAS
	 0.134
SE (	) 0.092
p 0.147
CERDAS
	 0.015
SE (	) 0.083
p 0.854
MRVAS
	 0.241
SE (	) 0.084
p 0.004
Note. All predictors remain significant after applying a Bonferroni cor-
rection of /8  .006. ITT  intention to treat; DASForm A  Dysfunc-
tional Attitude Scale Form A; CE cognitive extremity on the DAS before
mood provocation; CRDAS  cognitive reactivity on the DAS; CERDAS 
changes in cognitive extremity on the DAS following mood provocation;
MRVAS  mood reactivity on the Visual Analogue Scale.
Table 1
Demographic and Clinical Characteristics (N  172)
Variable
TAU
(n  84)
TAU  PCT
(n  88)
Characteristica
Female % (n) 73.8 (62) 72.7 (64)
Age 43.4 (9.8) 45.9 (9.1)
Previous episodes (median; IQR,
No.b)
3.0; 3.8, 2.8 4.0; 3.8, 2.9
Age of first onset 28.1 (12.5) 28.8 (12.6)
Patients on antidepressants % (n) 50.0 (42) 52.2 (46)
Cumulative relapse over 5.5 yearsc % 95 (79) 75 (82)
Median survival time over 5.5 yearsd 205.0 (502.0) 713.0 (502.0)
Pretreatment
HDRS17 3.7 (2.9) 3.8 (2.8)
DAS-A 129.4 (36.6) 119.2 (29.4)
DAS-B 122.4 (32.8) 114.4 (30.2)
CE 7.1 (9.0) 6.9 (6.6)
CRDAS 
7.0 (14.8) 
4.8 (18.5)
CERDAS 
1.4 (5.2) 
1.1 (4.4)
MRVAS 2.3 (2.4) 2.1 (2.3)
Post-treatment
HDRS17 6.5 (6.1) 4.0 (4.4)
DAS-A 122.4 (32.2) 113.4 (26.8)
DAS-B 118.6 (29.8) 109.8 (25.0)
CRDAS 
3.8 (16.2) 
3.6 (16.2)
CERDAS 
1.4 (4.3) 
0.9 (4.8)
MRVAS 2.1 (2.1) 1.7 (1.9)
Note. TAU treatment as usual; PCT preventive cognitive therapy; IQR
 interquartile range; HDRS17  17-item Hamilton Depression Rating Scale;
DAS-A  Dysfunctional Attitude Scale Form A; DAS-B  Dysfunctional
Attitude Scale Form B; CE cognitive extremity on the baseline DAS; CR
cognitive reactivity (post–pre induction DAS); CER  cognitive extremity
responding reactivity (post–pre induction extremity DAS); MR  mood
reactivity (post–pre induction Visual Analogue Scale [VAS]).
a All values represent M (SD) unless stated otherwise. b Average number
of dichotomized previous episodes (two or three and more). c Cumulative
relapse over 66 months in patients with four or more and, in parentheses,
with less than four previous major depressive episodes (MDEs). d Me-
dian survival time in weeks for patients with four or more previous and, in
parentheses, with less than four previous MDEs.
 p  .05.  p  .01.
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Until now, only post-treatment cognitive reactivity had been
examined (Kuyken et al., 2010; Segal et al., 1999, 2006). We
therefore repeated previous analyses for post-treatment cognitive
reactivity and cognitive extremity reactivity. Still, both were not
predictive for time to relapse: CR, Wald 2(1, N  172)  2.103,
p  .147, hazard ratio  1.14; CER, Wald 2(1, N  172) 
0.034, p  .854, hazard ratio  1.02, and the residuals of the DAS
change scores did not differ between patients who relapsed within
5.5 years and patients who did not, F(1, 170)  0.088, p  .767.
Although the mood provocation was successful overall, sadness
on the VAS did not increase with 10% in all patients. We
therefore repeated the cognitive reactivity analyses while selecting
patients on their level of increase in sadness on the VAS. The
results did not change when we selected patients with an increase
in sadness on the pretreatment VAS of at least 10% (n  121,
p  .335), and similarly of at least 20% (n  95, p  .709), 30%
(n  62, p  .825), 40% (n  36, p  .975), and 50% (n  20,
p  .781), respectively. Similar results were obtained for post-
treatment cognitive reactivity, although we could only select pa-
tients with a mood change up to 40%, since the number of events
(i.e., relapses) in the survival analysis was below 10 for patients
with a mood change of 50% or more (n  9; 4.8% of the sample).
Prediction of 5.5-Year Relapse by Mood Reactivity
Cox regression for change in negative mood following mood
provocation revealed that baseline mood reactivity did not predict
time to relapse within 5.5 years: MR, Wald 2(1, N  172) 
0.059, p  .807, hazard ratio  1.02. Furthermore, no difference
in relapse emerged between patients unresponsive to the mood
provocation (i.e., no mood response or positive mood increase;
n  26; 77% relapse) and patients experiencing a negative mood
(n  109; 79% relapse) (p  .455, Fisher exact test).
At post-treatment, however, higher mood reactivity was predic-
tive of time to relapse, Wald 2(1, N  172)  8.285, p  .004,
hazard ratio  1.27.
Effect of PCT on Cognitive Reactivity and Mood
Reactivity
In order to examine mediation by change in cognitive reactivity,
cognitive extremity reactivity, and mood reactivity on the effect of
PCT on relapse, we first examined whether the course (change
over 3 months) of reactivity measurements was predictive of
relapse. Patients who became increasingly mood reactive and
cognitive reactive (but not cognitive extremity reactive) were at
increased risk of relapse: CR, Wald 2(1, N  172)  6.765, p 
.009, hazard ratio 1.25; MR, Wald 2(1, N 172) 6.853, p
.009, hazard ratio  1.25; CER, Wald 2(1, N  172)  0.348,
p  .555, hazard ratio  0.96. However, after we selected patients
with four or more previous MDEs (for mediation purposes), the
course of reactivity measurements was no longer predictive of time
to relapse.
Second, PCT was not related to changes in cognitive reactivity,
cognitive extremity reactivity, or mood reactivity over time as
putative mediators on the effect of PCT on relapse (see Figure 1),
although PCT did prolong time to relapse in 5.5 years.
 
 
 
 
β = -0.26 (CI: -0.57, 0.05) 
β = 0.35 (CI: -0.11, 0.80) 
β = -0.31 (CI: -0.73, 0.12) 
β = -0.19 (CI: -0.47, 0.10) 
 β = 0.15 (CI: -0.07, 0.37) 
 β = 0.25 (CI: -0.02, 0.53) 
 β = 0.04 (CI: -0.15, 0.22)  
 β = 0.07 (CI: -0.18, 0.32)  
 
 
Preventive 
Cognitive 
Therapy 
β = -0.77 (CI: -1.25, -0.28) 
 
 
Time to relapse 
in 5.5 years 
a 
β = -0.77 (CI: -1.26, -0.29) 
β = -0.82 (CI: -1.30, -0.33) 
β = -0.80 (CI: -1.23, -0.32 ) 
β = -0.80 (CI: -1.28, -0.32)  
ΔCR 
ΔCER 
ΔMR 
ΔDAS 
b
d
e
c
Figure 1. Four multiple regression mediation models in patients with four or more previous major depressive
episodes. Change in cognitive reactivity (CR), cognitive extremity responding reactivity (CER), mood reactivity
(MR), and Dysfunctional Attitude Scale (DAS) were entered separately. a Represents the direct effect. b Represents
the 	 after CR was added to the model (effects of preventive cognitive therapy [PCT] mediated by CR  3.1%).
c Represents the 	 after CER was added to the model (effects of PCT mediated by CER  –2.3%). d Represents
the 	 after MR was added to the model (effects of PCT mediated by MR 3.9%). e Represents the 	 after DAS
was added to the model (effects of PCT mediated by DAS  
0.3%).
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Relative changes in beta’s when adding CR, CER, and MR
separately to the model with PCT alone were small and ranged
between 3.1 and 3.9%, indicating that the relation between PCT
and time to relapse was not mediated by change in cognitive
reactivity, cognitive extremity reactivity, or mood reactivity. Ad-
ditionally, we examined whether change in unprimed (latent) dys-
functional beliefs possibly mediated the preventive effect of PCT.
Mediation by unprimed dysfunctional beliefs was also not sup-
ported by our analyses (change in beta PCT  –0.3%). Similar
results were obtained for completers. Finally, we also replicated
previous mediation analysis with post-treatment cognitive reactiv-
ity only (Kuyken et al., 2010). Again, no indications for mediation
were found (see Table IV in the online supplemental materials).
Discussion
To our knowledge, this was the first study that prospectively
examined the combination of primed and unprimed cognitive and
emotional vulnerability as risk factors for relapse over 5.5 years.
Moreover, we are unaware of any studies that examined whether
changes in cognitive and emotional vulnerability mediated the
effect of PCT in preventing relapse over 5.5 years.
Our findings show that mood reactivity instead of cognitive
reactivity and cognitive extremity reactivity predicted relapse over
5.5 years. Further, unprimed dysfunctional beliefs predicted re-
lapse directly, whereas unprimed cognitive extremity did not. We
found no indication that cognitive reactivity mediated the effect of
PCT, which is in line with findings of Kuyken et al. (2010) using
MBCT. Finally, neither cognitive extremity reactivity, nor mood
reactivity or unprimed dysfunctional beliefs mediated the preven-
tive effect of PCT on relapse. Explorative analyses revealed that
the course of both cognitive reactivity and mood reactivity (i.e.,
increases in reactivity) was predictive of time to relapse.
Our finding that mood reactivity predicted relapse over 5.5 years
supports findings of several other studies, although their follow up
was restricted to a maximum of 12 months (Lethbridge & Allen,
2008; Rucci et al., 2011). Especially an increase in negative mood
(i.e., self-rated sadness) was predictive of relapse. Lethbridge and
Allen (2008) found that the absence of positive mood decrease
following mood provocation was predictive of 12-month relapse.
Recent studies on mood reactivity in depression highlight the role
of daily stress as a provoking factor for mood reactivity and
relapse in depressive symptomatology and highlight the role of
measuring mood reactivity in daily life (Bockting et al., 2006;
Britton et al., 2012; Bylsma, Taylor-Clift, & Rottenberg, 2011;
Peeters et al., 2010; ten Doesschate et al., 2009). We speculate that
patients who are highly reactive when confronted with a sad or
very stressful event might be more susceptible to experiencing
negative affect, in turn making them more vulnerable for relapse.
This is in line with previous studies that reported evidence for the
role of daily hassles and for the ability of lower severity life-events
to predict relapse and recurrence (Bockting et al., 2006; Cohen
et al., 2005; Monroe & Harkness, 2005; Stroud, Davila, Hammen,
& Vrshek-Schallhorn, 2011). Future studies should attempt to
unravel the link between mood reactivity and daily stress further.
The finding that cognitive reactivity does not play a role as risk
factor for relapse is in line with a previous study that was unable
to demonstrate that cognitive reactivity predicted relapse over 12
months in a community sample (Lethbridge & Allen, 2008). Nev-
ertheless, there is also supportive evidence for cognitive reactivity
as a vulnerability factor for relapse (Kuyken et al., 2010; Segal
et al., 1999, 2006). Explorative analyses revealed that the course of
cognitive reactivity over time was also predictive of relapse (i.e.,
patients with increases in cognitive reactivity over time were more
at risk). Cognitive reactivity might have to be assessed repeatedly
to detect its impact on relapse. Since no other study reported on the
course of cognitive reactivity, no firm conclusions can be drawn
and replication is required. Moreover, since the current study and
many previous studies found support for the prediction of relapse
by unprimed dysfunctional beliefs directly (Jarrett et al., 2012;
Rush, Weissenburger, & Eaves, 1986; Simons, Murphy, Levine, &
Wetzel, 1986; Thase et al., 1992), the practical question is raised
why one would use a complicated repeated mood provocation
instead of a single questionnaire (the DAS) in order to determine
vulnerability for relapse.
Our findings question the assumption that dysfunctional beliefs
have to be activated in the remitted phase to act as a vulnerability
factor (Miranda & Persons, 1988; Teasdale, 1988). Although we
found significant average change in dysfunctional beliefs follow-
ing both mood provocations (pretreatment: 5.9 points decrease,
post-treatment: 3.7 points decrease; ns between conditions), in line
with previous studies (Kuyken et al., 2010; Lethbridge & Allen,
2008; Miranda, Gross, Persons, & Hahn, 1998; Segal et al., 1999;
Van der Does, 2002, 2005), other studies did not (Jarrett et al.,
2012; Miranda & Persons, 1988). Moreover, differential dysfunc-
tional belief activation between remitted patients and never de-
pressed controls remains controversial (Brosse & Craighead, 1999;
Dykman, 1997; Fresco et al., 2006; Miranda et al., 1998; Otto et
al., 2007; Silverman, Silverman, & Eardley, 1984).
Finally, we found no indications for a modifying effect of PCT
on changes in dysfunctional beliefs (i.e., cognitive reactivity and
extremity reactivity) or mood reactivity, and moreover, no evi-
dence that changes in these reactivity measures mediated the effect
of PCT on reducing the risk of relapse. Yet, the preventive CT
used in this study was found to be effective in increasing survival
time and reducing cumulative relapse risk up to 5.5 years (Bock-
ting et al., 2005, 2009). Studies on potential mediators of CT after
remission have so far provided mixed results (Bieling et al., 2012;
Britton et al., 2012; Kuyken et al., 2010; Shahar et al., 2010).
Unfortunately, like the before mentioned studies, we were also
unable to pinpoint a mediator of the effect of CT after remission.
It is therefore currently still unknown how CT after remission
exerts its effects on relapse and recurrence.
The current study has several limitations. Differences in cogni-
tive reactivity between the current study and previous studies
could relate to differences in patient samples. Our sample con-
sisted of highly recurrent depressed patients currently in remission
(M  6.5 previous MDEs, compared to Ms  4.8, 1.9, and 6.1 in
Segal et al., 1999; Lethbridge & Allen, 2008; and Kuyken et al.,
2010, respectively). Particularly the sample of Segal et al. (2006)
differed in number of previous MDEs (average of dichotomized 1
vs. 2 or more previous MDEs was 1.69, compared to 2.81 in our
sample). For highly recurrent patients, vulnerability factors might
be different than for patients with fewer episodes (Bockting et al.,
2006; Daley, Hammen, & Rao, 2000; Lewinsohn, Allen, Seeley, &
Gotlib, 1999). Finally, the question remains whether laboratory-
induced sadness is generalizable to elicited sad mood in daily life,
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and what this contributes to our knowledge about vulnerability
factors for relapse.
In sum, the current study indicated that mood reactivity after
mood provocation predicted relapse in depression while cognitive
reactivity did not. Since unprimed dysfunctional beliefs did predict
time to relapse directly, the clinical usefulness of a repeated mood
provocation over a single DAS questionnaire is questioned. Future
studies in this area should focus not only on the experience of daily
sad mood and on the role of stress as a provoking factor of mood
reactivity, but also on the meaning of the course of cognitive
reactivity (i.e., changes in reactivity over time).
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